Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEIH.L Regulatory News (EIH)

  • There is currently no data for EIH

Net Asset Value(s)

26 Sep 2007 10:21

Evolvence India Holdings PLC26 September 2007 evolvence Evolvence India Holdings Announces its Net Asset Value* at 30 June 2007 • Company's net assets are US$68.8 million and net asset value per share is US$1.053 New Delhi, India: 26 September 2007 - Evolvence India Holdings plc ("EIH" or"the Company"), an Isle of Man, private equity fund of funds holding companythat focuses on India, today announced its unaudited net asset value as of June 30, 2007, being its second update since admitting to AIM on 23 March 2007. The Company's net assets, at that date, are valued at $ 68.44 million and netasset value per share is $1.053, based on 65 million ordinary shares issuedduring an initial public offering of common stock on AIM, a market of the LondonStock Exchange plc, EIH has committed $45.1 million of the net proceeds intoEvolvence India Fund ("EIF"), an established private equity fund of funds with aco-investment pool focusing on growth capital in India. The Company has alsocommitted $6 million to the Evolvence India Life Sciences Fund, ("EILSF") aprivate equity fund for investments in life sciences businesses in India. The Company's investment objective is to give investors access to a diversifiedIndian private equity portfolio while mitigating issues usually associated withprivate equity investments, such as lack of liquidity and relatively largeminimum investment size. Evolvence India Fund closed with US$250 million in commitments, EIF's portfolioincludes investments in eight funds focused on private equity, real estate andinfrastructure and six co-investments. The number of portfolio companies (directand underlying fund investments) stands at 70 in well diversified growth sectorsof the Indian economy. The portfolio has had six successful full exits and threepartial exits. This includes the successful listing of Zylog Systems, a leadingtechnology driven business solutions service provider and a portfolio company ofthe fund, on 17th August 2007. The IPO was oversubscribed by 76.5 times andlisted at a considerable premium to the IPO issue price. Apparel retailerKoutons Retail India Ltd also successfully raised 1.46 billion Indian rupeesthrough an offer of 3.5 million shares on September 24, 2007, This IPO wassubscribed 45,52 times. Consolidated Construction Ltd (CCL) closed thesubscription to its initial public offer on September 21, 2007, The issue wasover subscribed by about 81 times. "We continue to execute on our strategy of investing in best of breed managersand companies," said Jay Jegannathan, CEO, Evolvence India Holdings. "With moreexits in the pipeline, we believe the portfolio will reflect the true potentialof our investments. To date, EIF's portfolio includes investments in sevenprivate equity funds including Baring India Private Equity Fund II, IDFC PrivateEquity Fund II, India Value Fund II. Leverage India Fund, New York LifeInvestment Management India Fund, Ascent India Fund and JM Financial India Fund.EIF has also made five co-investments, to date, and this on course to generatesuperior returns." According to a recent Bloomberg report, India's economic growth unexpectedlyaccelerated last quarter, with stocks and the Indian rupee extending gains.SouthAsia's largest economy expanded 9.3 percent in the three months to June 30 froma year earlier, after gaining 9.1 percent in the previous quarter. Growth inIndia in the third quarter of this year compares with a gain of 1.8 percent inthe U.S., 2.5 percent in countries sharing the Euro, and 2.3 percent in Japan.China's economy grew 11.9 percent. "EIH provides investors with the ability to participate in the Indian growthstory through a diversified private equity portfolio without the usual barriersassociated with direct private equity investments," added Jegannathan. Results of EIH Operations: Amount raised in IPO; $ 65.0 millionNet proceeds: $ 60.0 millionCommitted to Evolvence India Fund: $ 45.1 millionCommitted to Evolvence India Life Sciences Fund $ 6.0 millionUncommitted Capital $ 17.7 million Unaudited Valuation as of 31-6-2007* • NAV $68.5 million • NAV per unit $1,053 * Adjusted for Exchange Rate - Ends- About Evolvence India Holding (EIH): EIH is an Isle of Man incorporated, private equity fund of funds holding companyfocused on India. EIH is promoted by Evolvence Capital Ltd, a Dubai basedalternative investment firm, EIH invests in India through Evolvence India Fundand Evolvence India Life Sciences Fund and the fund managers' network ofrelationships. The funds advisors are based in New Delhi and Hyderabad. Contacts: Evolvence India Holdings plcJay Jegannathan, Chief Executive Officer + 91. 98.188. 99 90 Evolvence CapitalShilpa Mathai, Communications Manager + (971) 4 332 4033 shilpa@evolvence.com Fairfax I.SJonathan Brown, Head of Smaller Companies + (44) 20 7460 4385 Seymour PierceJonathan Wright, Director, Corporate Finance + (44) 20 7107 8050 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
7th May 202011:49 amRNSResult of EGM and Notice of Cancellation
7th Apr 20207:00 amRNSProposed AIM Cancellation and Notice of EGM
2nd Apr 20205:38 pmRNSReturn of Capital and COVID-19 Update
6th Dec 20197:00 amRNSReturn of Capital
29th Nov 20197:00 amRNSDelisting Update
21st Nov 20197:00 amRNSMarket Update
30th Sep 20194:30 pmRNSInterim Results
30th Jul 201911:15 amRNSResult of AGM
28th Jun 20197:00 amRNSPosting of 2018 Annual Results and Notice of AGM
24th May 20195:53 pmRNSHolding(s) in Company
1st May 20197:00 amRNSReturn of Capital
4th Apr 20195:00 pmRNSSale of RSB and Return of Capital
25th Jan 20197:00 amRNSHolding(s) in Company
21st Jan 20196:13 pmRNSHolding(s) in Company
18th Jan 201911:37 amRNSHolding(s) in Company
28th Sep 20187:00 amRNSInterim Results
26th Jul 201811:05 amRNSResult of AGM
28th Jun 20187:00 amRNSPosting of 2017 Annual Report and Notice of AGM
28th Jun 20187:00 amRNSReturn of Capital
20th Mar 20181:00 pmRNSReplacement: Return of Capital
20th Mar 20187:00 amRNSReturn of Capital
29th Sep 20175:17 pmRNSHalf-year Report
29th Sep 20175:13 pmRNSReturn of capital
24th Jul 201710:54 amRNSResults of Annual General Meeting
26th Jun 20176:01 pmRNSDirectorate Change
26th Jun 20176:00 pmRNSPosting of 2016 Annual Report and Notice of AGM
9th Feb 20178:05 amRNSReturn of Capital
26th Jan 20175:08 pmRNSHolding(s) in Company
25th Jan 20179:30 amRNSHolding(s) in Company
5th Jan 20177:00 amRNSUpdate re EIF
30th Sep 20167:00 amRNSHalf-year Report
25th Jul 20161:24 pmRNSResult of AGM
27th Jun 20165:37 pmRNSPosting of Annual Report & Notice of AGM
27th Jun 20167:00 amRNSReturn of Capital
27th Jun 20167:00 amRNSFinal Results
30th Nov 20155:57 pmRNSHolding(s) in Company
30th Sep 20157:00 amRNSInterim Results
30th Jun 201511:53 amRNSResult of AGM
9th Jun 20154:00 pmRNSNotice of AGM
5th Jun 20154:35 pmRNSFinal Results
30th Sep 20147:00 amRNSHalf Yearly Report
14th Jul 20143:19 pmRNSReturn of Capital
30th Jun 201411:57 amRNSResult of AGM
4th Jun 20147:00 amRNSNotice of AGM
3rd Jun 20147:00 amRNSFinal Results
3rd Dec 201311:16 amRNSHolding(s) in Company
2nd Dec 20134:09 pmRNSHolding(s) in Company
28th Nov 20135:14 pmRNSHolding(s) in Company
27th Nov 20133:14 pmRNSSale of Interest in Gland Pharma Limited
22nd Nov 20139:15 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.